Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Peerlinck

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Characteristics of inhibitors in mild/moderate haemophilia AK Peerlinck, M Jacquemin
The New England Journal of Medicine|July 17, 1999
Transfusion medicineP Vandenberghe, K Peerlinck
Acta Clinica Belgica|January 1, 1991
Epidemic of factor VIII inhibitors linked to factor VIII-PJ Vermylen, K Peerlinck
Vox Sanguinis|January 1, 1994
Review of the hepatitis A epidemics in hemophiliacs in EuropeJ Vermylen, K Peerlinck
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
Mild haemophilia: a disease with many faces and many unexpected pitfallsK Peerlinck, M Jacquemin
Thrombosis and Haemostasis|December 29, 1999
Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitorK Peerlinck, J Vermylen
Lancet (London, England)|August 12, 1995
Fatal complication of desmopressinJ Vermylen, K Peerlinck
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 7, 2006
Epidemiology of inhibitor formation with recombinant factor VIII replacement therapyK Peerlinck, C Hermans
Lancet (London, England)|January 16, 1993
Acute hepatitis A in patients with haemophilia AK Peerlinck, J Vermylen
European Journal of Haematology. Supplementum|January 12, 1999
Optimal care of inhibitor patients during surgeryJ Vermylen, K Peerlinck
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Characteristics of inhibitors in mild/moderate haemophilia AK Peerlinck, M Jacquemin
The New England Journal of Medicine|July 17, 1999
Transfusion medicineP Vandenberghe, K Peerlinck
Acta Clinica Belgica|January 1, 1991
Epidemic of factor VIII inhibitors linked to factor VIII-PJ Vermylen, K Peerlinck
Vox Sanguinis|January 1, 1994
Review of the hepatitis A epidemics in hemophiliacs in EuropeJ Vermylen, K Peerlinck
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
Mild haemophilia: a disease with many faces and many unexpected pitfallsK Peerlinck, M Jacquemin
Thrombosis and Haemostasis|December 29, 1999
Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitorK Peerlinck, J Vermylen
Lancet (London, England)|August 12, 1995
Fatal complication of desmopressinJ Vermylen, K Peerlinck
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 7, 2006
Epidemiology of inhibitor formation with recombinant factor VIII replacement therapyK Peerlinck, C Hermans
Lancet (London, England)|January 16, 1993
Acute hepatitis A in patients with haemophilia AK Peerlinck, J Vermylen
European Journal of Haematology. Supplementum|January 12, 1999
Optimal care of inhibitor patients during surgeryJ Vermylen, K Peerlinck
Pageof 9